Medavail Holdings Inc

MedAvail Holdings, Inc. is a technology-enabled pharmacy company, which engages in the development and commercialization of a self-service pharmacy, mobile application, kiosk, and drive-thru solution. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment comprises the MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Mississauga, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. The Retail Pharmacy Services segment includes MedAvail Pharmacy Inc. and does business under the trade name SpotRx Pharmacy. The Pharmacy Technology segment represents MedAvail Technologies Inc. that sells the system including MedCenter prescription dispensing kiosk, software, integration, and maintenance services. The company was founded on April 11, 2007 and is headquartered in Phoenix, AZ.

Expands MedAvail's presence among Federally Qualified Health Centers (FQHCs) Expands MedAvail's presence among Federally Qualified Health Centers (FQHCs)

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 with the Securities and Exchange Commission.

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q

Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy Fund 1 also operates Oaklawn Pharmacy, which is a current MedAvail partner in Dallas, Texas.

MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023.

MedAvail Reports Second Quarter 2023 Financial Results

Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution

MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters

PHOENIX, Ariz., July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50. The reverse stock split will become effective at 5:00 p.m. Eastern time, on July 31, 2023. The Company's common stock will begin trading on a post-split basis at the market open on August 1, 2023, under the Company's existing trading symbol “MDVL”. The CUSIP number for the common stock following the reverse stock split will be 58406B 202. The reverse stock split is part of the Company's plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share for continued listing on The Nasdaq Capital Market.

MedAvail Announces 1-for-50 Reverse Stock Split

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q1 2023 Results Conference Call May 18, 2023 4:30 PM ET Company Participants Steve Halper - Managing Director at LifeSci Advisors Mark Doerr - Chief Executive Officer Ramona Seabaugh - Chief Financial Officer Conference Call Participants Lucas Romanski - TD Cowen Operator Hello, everyone. And thank you for joining MedAvail's 2023 First Quarter Conference Call.

MedAvail Holdings, Inc. (MDVL) Q1 2023 Earnings Call Transcript

PHOENIX, May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023.

MedAvail Reports First Quarter 2023 Financial Results

Management to host investor conference call and webcast at 4:30pm EDT today Management to host investor conference call and webcast at 4:30pm EDT today

MedAvail to Report First Quarter 2023 Financial Results on May 18

PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the quarter ended March 31, 2023 previously scheduled for today.

MedAvail Postpones Reporting of First Quarter 2023 Financial Results

Management to host investor conference call and webcast at 4:30 pm EDT today Management to host investor conference call and webcast at 4:30 pm EDT today

MedAvail to Report First Quarter 2023 Financial Results on May 15

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q4 2022 Earnings Conference Call April 13, 2023 4:30 PM ET Company Participants Steven Halper - MD, LifeSci Advisors, IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Charles Rhyee - Cowen & Co. Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Fourth Quarter and Full Year Conference Call. My name is Doug.

MedAvail Holdings, Inc. (MDVL) Q4 2022 Earnings Call Transcript

PHOENIX, April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022.

MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results

Management to host investor conference call and webcast at 4:30pm EDT on that day Management to host investor conference call and webcast at 4:30pm EDT on that day

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13

PHOENIX, March 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the fourth quarter and full-year ended December 31, 2022 previously scheduled for today.

MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results

Management to host investor conference call and webcast at 4:30pm ET on that day Management to host investor conference call and webcast at 4:30pm ET on that day

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30

PHOENIX, March 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that on March 13, 2023, it closed a private placement (the “Offering”) of securities with certain institutional investors pursuant to the terms of a definitive securities purchase agreement dated March 9, 2023.  The Offering consists of pre-funded warrants to purchase common stock (the “Pre-Funded Warrants”) that were issued upon the closing at a price of $0.3212 per underlying share and are exercisable into shares of common stock at an exercise price of $0.001 per share, as well as Series A warrants to purchase common stock an exercise price of $0.385440 per share (the “Series A Warrants”) that will be issued following stockholder approval of the Offering. The Pre-Funded Warrant shares are exercisable for an aggregate of up to 49,813,198 shares of common stock, and the Series A Warrants would be exercisable for an aggregate of up to 49,813,198 shares of common stock.  MedAvail received gross proceeds from the Offering of approximately $16 million, before deducting offering expenses.

MedAvail Announces Closing of $16 Million Private Placement

PHOENIX, Jan. 26, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative technology-enabled pharmacy company, today announced it has entered into a definitive agreement with CVS Pharmacy, Inc., on behalf of itself and its subsidiaries and affiliates (“CVS”), for the sale of certain assets of MedAvail's SpotRx pharmacies (the “CVS Transaction”).

MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy

Company focusing on innovative technology and exit of pharmacy services

MedAvail announces Strategic Restructuring of Business to Focus on Profitability

AppHarvest

Herbalife

United Natural Foods

Tattooed Chef

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. Here's the latest list of major oversold players in this sector.

Most Oversold Stocks In Consumer Staples Sector: Herbalife, United Natural Foods And More - Herbalife Nutrition (NYSE:HLF), AppHarvest (NASDAQ:APPH)

PHOENIX, Nov. 28, 2022 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that on November 22, 2022, the compensation committee of MedAvail's board of directors approved the grant of inducement awards to five newly-hired employees.  The inducement awards cover an aggregate of 445,060 shares of MedAvail's common stock, of which 50% are options to purchase and 50% are restricted stock units (RSUs).

MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

MedAvail Holdings, Inc. (NASDAQ:MDVL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Ji-Yon Yi - IR Mark Doerr - CEO Ramona Seabaugh - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Hello, everyone, and thank you for joining the MedAvail's 2022 Third Quarter Earnings Conference Call. My name is Daren, I'll be your operator for today.

MedAvail Holdings, Inc. (MDVL) Q3 2022 Earnings Call Transcript

MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022

MIAMI & MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-based retail pharmacy company, and Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care”) a personalized healthcare services and technology company, are excited to announce a technology agreement to deploy five MedAvail MedCenters in Florida.

MedAvail Announces Technology Partnership with Progressive Care, Inc

MISSISSAUGA, Ontario & PHOENIX, Ariz.--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York. MedAvail's management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Invest

News for Medavail Holdings Inc Stock (MDVL)